The changes of prevalence and etiology of pediatric pneumonia from National Emergency Department Information System in Korea, between 2007 and 2014
- PMID: 30274507
- PMCID: PMC6172518
- DOI: 10.3345/kjp.2017.06100
The changes of prevalence and etiology of pediatric pneumonia from National Emergency Department Information System in Korea, between 2007 and 2014
Abstract
Purpose: Understanding changes in pathogen and pneumonia prevalence among pediatric pneumonia patients is important for the prevention of infectious diseases.
Methods: We retrospectively analyzed data of children younger than 18 years diagnosed with pneumonia at 117 Emergency Departments in Korea between 2007 and 2014.
Results: Over the study period, 329,380 pediatric cases of pneumonia were identified. The most frequent age group was 1-3 years old (48.6%) and the next was less than 12 months of age (17.4%). Based on International Classification of Diseases, 10th revision diagnostic codes, confirmed cases of viral pneumonia comprised 8.4% of all cases, pneumonia due to Mycoplasma pneumoniae comprised 3.8% and confirmed cases of bacterial pneumonia 1.3%. The prevalence of confirmed bacterial pneumonia decreased from 3.07% in 2007 and 4.01% in 2008 to 0.65% in 2014. The yearly rate of pneumococcal pneumonia also decreased from 0.47% in 2007 to 0.08% in 2014. A periodic prevalence of M. pneumoniae pneumonia (MP) was identified.
Conclusion: The increased number of patients with pneumonia, bacterial pneumonia, pleural effusion, and empyema in 2011 and 2013-2014 resulted from an MP epidemic. We provide evidence that the frequency of confirmed cases of bacterial pneumonia and pneumococcal pneumonia has declined from 2007 to 2014, which can simultaneously reflect the effectiveness of the pneumococcal conjugate vaccine.
Keywords: Community acquired infections; Interrupted time series analysis; Pneumonia.
Conflict of interest statement
No potential conflict of interest relevant to this article was reported.
Figures




Similar articles
-
Long-term Association of 13-Valent Pneumococcal Conjugate Vaccine Implementation With Rates of Community-Acquired Pneumonia in Children.JAMA Pediatr. 2019 Apr 1;173(4):362-370. doi: 10.1001/jamapediatrics.2018.5273. JAMA Pediatr. 2019. PMID: 30715140 Free PMC article.
-
Change in Bacterial Causes of Community-Acquired Parapneumonic Effusion and Pleural Empyema in Children 6 Years After 13-Valent Pneumococcal Conjugate Vaccine Implementation.J Pediatric Infect Dis Soc. 2019 Nov 6;8(5):474-477. doi: 10.1093/jpids/piy103. J Pediatric Infect Dis Soc. 2019. PMID: 30407519
-
Early impact of 13-valent pneumococcal conjugate vaccine on community-acquired pneumonia in children.Clin Infect Dis. 2014 Apr;58(7):918-24. doi: 10.1093/cid/ciu006. Epub 2014 Feb 13. Clin Infect Dis. 2014. PMID: 24532543
-
Community-acquired pneumonia in the post 13-valent pneumococcal conjugate vaccine era.Curr Opin Pediatr. 2016 Dec;28(6):786-793. doi: 10.1097/MOP.0000000000000428. Curr Opin Pediatr. 2016. PMID: 27755118 Review.
-
[Community-acquired pneumonia: prospective study of 101 adult, immunocompetent patients for 1 year].Enferm Infecc Microbiol Clin. 1993 Dec;11(10):525-30. Enferm Infecc Microbiol Clin. 1993. PMID: 8142501 Review. Spanish.
Cited by
-
Etiology and Clinical Characteristics of Community-Acquired Pneumonia in Korean Children During the Pre-COVID-19 Period, 2015-2020.J Korean Med Sci. 2023 Nov 6;38(43):e339. doi: 10.3346/jkms.2023.38.e339. J Korean Med Sci. 2023. PMID: 37935166 Free PMC article.
-
Associations between Delayed Introduction of Complementary Foods and Childhood Health Consequences in Exclusively Breastfed Children.Nutrients. 2023 Jul 31;15(15):3410. doi: 10.3390/nu15153410. Nutrients. 2023. PMID: 37571347 Free PMC article.
-
Recent Macrolide Resistance Pattern of Mycoplasma Pneumonia in the World: A Systematic Review and Meta-Analysis.Iran J Public Health. 2025 Mar;54(3):530-541. doi: 10.18502/ijph.v54i3.18246. Iran J Public Health. 2025. PMID: 40330176 Free PMC article. Review.
-
Necrotizing Pneumonia in Children: Early Recognition and Management.J Clin Med. 2023 Mar 14;12(6):2256. doi: 10.3390/jcm12062256. J Clin Med. 2023. PMID: 36983257 Free PMC article. Review.
-
Clinical efficacy of macrolide antibiotics in mycoplasma pneumoniae pneumonia carrying a macrolide-resistant mutation in the 23 S rRNA gene in pediatric patients.BMC Infect Dis. 2024 Jul 31;24(1):758. doi: 10.1186/s12879-024-09612-6. BMC Infect Dis. 2024. PMID: 39085799 Free PMC article.
References
-
- Michelow IC, Olsen K, Lozano J, Rollins NK, Duffy LB, Ziegler T, et al. Epidemiology and clinical characteristics of community-acquired pneumonia in hospitalized children. Pediatrics. 2004;113:701–7. - PubMed
-
- Yum HY, Kim WK, Kim JT, Kim HH, Rha YH, Park YM, et al. The causative organisms of pediatric empyema in Korea. Korean J Pediatr. 2007;50:33–9.
-
- Lee YH, Shin YL, Suh WS, Shin MY, Park JO. A clinical study of lobar/lobular pneumonia in children. Pediatr Allergy Respir Dis. 2009;19:271–81.
LinkOut - more resources
Full Text Sources